Targeted Treatment of B-Cell Malignancies: Practical Strategies for BTK Inhibitors

Expert faculty discuss pharmacist considerations with BTK inhibitors for patients with CLL and MCL in a downloadable slideset, commentary, and on-demand webcast from a live webinar.

Share

Supporters

Supported by an educational grant from

Pharmacyclics LLC, an AbbVie Company

Partners

National Association of Specialty Pharmacy

ProCE Banner